USE OF OLIGONUCLEOTIDES TO DEFINE THE SITE OF INTERSTRAND CROSS-LINKS INDUCED BY ADRIAMYCIN

被引:43
作者
CUTTS, SM [1 ]
PHILLIPS, DR [1 ]
机构
[1] LA TROBE UNIV,SCH BIOCHEM,BUNDOORA,VIC 3083,AUSTRALIA
基金
澳大利亚研究理事会;
关键词
D O I
10.1093/nar/23.13.2450
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been known for several years that Adriamycin forms adducts and interstrand cross-links when reacted for long periods of time with bacterial and mammalian DNA in vitro, with the cross-link being restricted to 2 bp elements containing GpC sequences, The self-complementary 20mer deoxyoligon ucleotide TA(4)T(4)GCA(4)T(4)A has been used in this study as a model of the apparent G-G cross-linking site at GpC sequences, The rate of formation of cross-links, as well as the dependence on both Adriamycin and Fe(III) concentration, were similar with this oligonucleotide as compared with calf thymus DNA, The cross-linking was demonstrated on both denaturing and non-denaturing sequencing gels, The half-life of the G-G cross-link was 40 h, consistent with that implied with high molecular weight, heterogeneous sequence DNA. Exonuclease III digests of adducts formed with 20mer deoxyoligonucleotides containing single, central G-G, G-I and I-I potential cross-links revealed that a guanine residue is required at both ends of the cross-link. No cross-linking was observed with a similar oligonucleotide containing only a single central (G . C) bp.
引用
收藏
页码:2450 / 2456
页数:7
相关论文
共 50 条
[1]   NADPH CYTOCHROME-P-450 REDUCTASE ACTIVATION OF QUINONE ANTI-CANCER AGENTS TO FREE-RADICALS [J].
BACHUR, NR ;
GORDON, SL ;
GEE, MV ;
KON, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (02) :954-957
[2]   ENHANCEMENT OF DOXORUBICIN TOXICITY FOLLOWING ACTIVATION BY NADPH CYTOCHROME P450 REDUCTASE [J].
BARTOSZEK, A ;
WOLF, CR .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (07) :1449-1457
[3]   COMPARISON OF DNA CLEAVAGE INDUCED BY ETOPOSIDE AND DOXORUBICIN IN 2 HUMAN SMALL-CELL LUNG-CANCER LINES WITH DIFFERENT SENSITIVITIES TO TOPOISOMERASE II INHIBITORS [J].
BINASCHI, M ;
CAPRANICO, G ;
DEISABELLA, P ;
MARIANI, M ;
SUPINO, R ;
TINELLI, S ;
ZUNINO, F .
INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (02) :347-352
[4]   DNA TOPOISOMERASE-TRAPPING ANTITUMOR DRUGS [J].
CAPRANICO, G ;
ZUNINO, F .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (12) :2055-2060
[5]  
CAPRANICO G, 1989, CANCER RES, V49, P2022
[6]   EXAMINATION BY LASER-SCANNING CONFOCAL FLUORESCENCE IMAGING MICROSCOPY OF THE SUBCELLULAR-LOCALIZATION OF ANTHRACYCLINES IN PARENT AND MULTIDRUG-RESISTANT CELL-LINES [J].
COLEY, HM ;
AMOS, WB ;
TWENTYMAN, PR ;
WORKMAN, P .
BRITISH JOURNAL OF CANCER, 1993, 67 (06) :1316-1323
[7]   DOES ADRIAMYCIN INDUCE INTERSTRAND CROSS-LINKS IN DNA [J].
CULLINANE, C ;
VANROSMALEN, A ;
PHILLIPS, DR .
BIOCHEMISTRY, 1994, 33 (15) :4632-4638
[8]   INDUCTION OF STABLE TRANSCRIPTIONAL BLOCKAGE SITES BY ADRIAMYCIN - GPC SPECIFICITY OF APPARENT ADRIAMYCIN DNA ADDUCTS AND DEPENDENCE ON IRON(III) IONS [J].
CULLINANE, C ;
PHILLIPS, DR .
BIOCHEMISTRY, 1990, 29 (23) :5638-5646
[9]   FORMATION OF ADRIAMYCIN - DNA-ADDUCTS IN-VITRO [J].
CULLINANE, C ;
CUTTS, SM ;
VANROSMALEN, A ;
PHILLIPS, DR .
NUCLEIC ACIDS RESEARCH, 1994, 22 (12) :2296-2303
[10]   THE ENZYMOLOGY OF DOXORUBICIN QUINONE REDUCTION IN TUMOR-TISSUE [J].
CUMMINGS, J ;
ALLAN, L ;
WILLMOTT, N ;
RILEY, R ;
WORKMAN, P ;
SMYTH, JF .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (11) :2175-2183